XML 43 R22.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Business Segments | 9 Months Ended
--- | ---
Mar. 31, 2014
Segment Reporting [Abstract] |
Business Segments | 14. Business Segments The Animal Health segment manufactures and markets products for the poultry, swine, cattle, dairy, aquaculture and ethanol markets. The business includes net sales of medicated feed additives and other related products, nutritional specialty products and vaccines. The Mineral Nutrition segment manufactures and markets trace minerals for the cattle, swine, poultry and pet food markets. The Performance Products segment manufactures and markets a variety of products for use in the personal care, automotive, industrial chemical and chemical catalyst industries. We evaluate performance and allocate resources based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments. We do not allocate such items to the principal segments because they are not used to evaluate their operating results or financial position. Corporate costs include the departmental operating costs of the Board of Directors, the Chairman and President, the Chief Executive Officer, the Chief Financial Officer, the General Counsel, the Senior Vice President of Human Resources, the Chief Information Officer and the Business Development function. Costs include the executives and their staffs and include compensation and benefits, outside services, professional fees and office space. Assets include certain cash and cash equivalents, debt issue costs and certain other assets. We evaluate performance of our segments based on Adjusted EBITDA. We define Adjusted EBITDA as EBITDA plus (a) (income) loss from, and disposal of, discontinued operations, (b) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses and loss on extinguishment of debt, and (c) certain items that we consider to be unusual or non-recurring. We define EBITDA as net income plus (i) interest expense, net, (ii) provision for income taxes or less benefit for income taxes, and (iii) depreciation and amortization. The accounting policies of our segments are the same as those described in the summary of significant accounting policies included in the Registration Statement.
​ | ​ | ​ | ​ | Three Months | ​ | ​ | Nine Months | ​
--- | --- | --- | --- | --- | --- | --- | --- | ---
​ | For the Periods Ended March 31 | ​ | ​ | 2014 | ​ | ​ | 2013 | ​ | ​ | 2014 | ​ | ​ | 2013 | ​
​ | Net sales | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​
​ | Animal Health | ​ | ​ | ​ | $ | 107,808 |  | ​ | ​ | ​ | ​ | $ | 93,883 |  | ​ | ​ | ​ | ​ | $ | 316,945 |  | ​ | ​ | ​ | ​ | $ | 284,247 |  | ​ | ​
​ | Mineral Nutrition | ​ | ​ | ​ | ​ | 49,901 |  | ​ | ​ | ​ | ​ | ​ | 51,757 |  | ​ | ​ | ​ | ​ | ​ | 146,720 |  | ​ | ​ | ​ | ​ | ​ | 154,441 |  | ​ | ​
​ | Performance Products | ​ | ​ | ​ | ​ | 15,558 |  | ​ | ​ | ​ | ​ | ​ | 17,045 |  | ​ | ​ | ​ | ​ | ​ | 44,572 |  | ​ | ​ | ​ | ​ | ​ | 50,262 |  | ​ | ​
​ | ​ | ​ | ​ | ​ | $ | 173,267 |  | ​ | ​ | ​ | ​ | $ | 162,685 |  | ​ | ​ | ​ | ​ | $ | 508,237 |  | ​ | ​ | ​ | ​ | $ | 488,950 |  | ​ | ​
​ | Adjusted EBITDA | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​
​ | Animal Health | ​ | ​ | ​ | $ | 25,505 |  | ​ | ​ | ​ | ​ | $ | 20,334 |  | ​ | ​ | ​ | ​ | $ | 74,134 |  | ​ | ​ | ​ | ​ | $ | 59,953 |  | ​ | ​
​ | Mineral Nutrition | ​ | ​ | ​ | ​ | 2,807 |  | ​ | ​ | ​ | ​ | ​ | 3,439 |  | ​ | ​ | ​ | ​ | ​ | 8,145 |  | ​ | ​ | ​ | ​ | ​ | 9,304 |  | ​ | ​
​ | Performance Products | ​ | ​ | ​ | ​ | 906 |  | ​ | ​ | ​ | ​ | ​ | 1,577 |  | ​ | ​ | ​ | ​ | ​ | 3,105 |  | ​ | ​ | ​ | ​ | ​ | 4,548 |  | ​ | ​
​ | Corporate | ​ | ​ | ​ | ​ | (6,774 | ) | ​ | ​ | ​ | ​ | ​ | (5,930 | ) | ​ | ​ | ​ | ​ | ​ | (19,032 | ) | ​ | ​ | ​ | ​ | ​ | (17,702 | ) | ​ | ​
​ | ​ | ​ | ​ | ​ | $ | 22,444 |  | ​ | ​ | ​ | ​ | $ | 19,420 |  | ​ | ​ | ​ | ​ | $ | 66,352 |  | ​ | ​ | ​ | ​ | $ | 56,103 |  | ​ | ​
​ | Adjusted EBITDA to income before income taxes | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​
​ | Adjusted EBITDA | ​ | ​ | ​ | $ | 22,444 |  | ​ | ​ | ​ | ​ | $ | 19,420 |  | ​ | ​ | ​ | ​ | $ | 66,352 |  | ​ | ​ | ​ | ​ | $ | 56,103 |  | ​ | ​
​ | Depreciation and amortization | ​ | ​ | ​ | ​ | (5,122 | ) | ​ | ​ | ​ | ​ | ​ | (4,959 | ) | ​ | ​ | ​ | ​ | ​ | (15,615 | ) | ​ | ​ | ​ | ​ | ​ | (14,277 | ) | ​ | ​
​ | Interest expense, net | ​ | ​ | ​ | ​ | (8,744 | ) | ​ | ​ | ​ | ​ | ​ | (8,875 | ) | ​ | ​ | ​ | ​ | ​ | (26,198 | ) | ​ | ​ | ​ | ​ | ​ | (26,655 | ) | ​ | ​
​ | Foreign currency (gains) losses, net | ​ | ​ | ​ | ​ | (275 | ) | ​ | ​ | ​ | ​ | ​ | (838 | ) | ​ | ​ | ​ | ​ | ​ | (2,088 | ) | ​ | ​ | ​ | ​ | ​ | (1,132 | ) | ​ | ​
​ | Other (income) expense, net | ​ | ​ | ​ | ​ | — |  | ​ | ​ | ​ | ​ | ​ | (482 | ) | ​ | ​ | ​ | ​ | ​ | — |  | ​ | ​ | ​ | ​ | ​ | (528 | ) | ​ | ​
​ | Income before income taxes | ​ | ​ | ​ | $ | 8,303 |  | ​ | ​ | ​ | ​ | $ | 4,266 |  | ​ | ​ | ​ | ​ | $ | 22,451 |  | ​ | ​ | ​ | ​ | $ | 13,511 |  | ​ | ​
​ | ​ | ​ | ​ |  |  | ​ |  | ​ | ​ |  |  | ​ |  | ​ | ​ |  |  | ​ |  | ​ | ​ |  |  | ​ |  | ​
​ | As of | ​ | ​ | March 31, 2014 | ​ | ​ | June 30, 2013 | ​
--- | --- | --- | --- | --- | --- | --- | --- | ---
​ | Identifiable assets | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | Animal Health | ​ | ​ | ​ | $ | 357,104 |  | ​ | ​ | ​ | ​ | $ | 354,422 |  | ​ | ​
​ | Mineral Nutrition | ​ | ​ | ​ | ​ | 58,910 |  | ​ | ​ | ​ | ​ | ​ | 62,933 |  | ​ | ​
​ | Performance Products | ​ | ​ | ​ | ​ | 23,500 |  | ​ | ​ | ​ | ​ | ​ | 21,710 |  | ​ | ​
​ | Corporate | ​ | ​ | ​ | ​ | 33,763 |  | ​ | ​ | ​ | ​ | ​ | 35,077 |  | ​ | ​
​ | ​ | ​ | ​ | ​ | $ | 473,277 |  | ​ | ​ | ​ | ​ | $ | 474,142 |  | ​ | ​
​ | ​ | ​ | ​ |  |  | ​ |  | ​ | ​ |  |  | ​ |  | ​
All goodwill is included in the Animal Health segment. During our fiscal quarter ended December 31, 2013, we reorganized our reportable segments for financial reporting to better align them with how we currently review operating results for purposes of allocating resources and managing performance. We created two new reportable segments, the Animal Health segment and the Mineral Nutrition segment, and eliminated the Animal Health & Nutrition (AH&N) segment. The Animal Heath segment consists of the business units within the former AH&N segment, excluding the Mineral Nutrition business unit, which is now a separate reportable segment. In accordance with ASC No. 280, “Segment Reporting” (“ASC 280”), we have reclassified all amounts to conform to our new reportable segment presentation.

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration